or Try an Advanced Search...

    Treatment Of Hemophilia Stocks List

    Symbol Grade Name % Change
    CNTA D Centessa Pharmaceuticals plc -6.00
    ALNY F Alnylam Pharmaceuticals, Inc. 0.19
    BIIB F Biogen Idec Inc. -0.48
    QURE F uniQure N.V. -1.45
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hemophilia Acute Intermittent Porphyria Biopharmaceutical Biotechnology Clinical Development Deficiency Hemophilia A Idiopathic Pulmonary Fibrosis Lupus Spinal Muscular Atrophy Adeno Associated Virus Alipogene Tiparvovec Alnylam Pharmaceuticals Alpha 1 Antitrypsin Alpha 1 Antitrypsin Deficiency Alzheimer's Disease Amyloid Amyloidosis Antitrypsin Deficiency Applied Genetics

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hemophilia stocks.

    Symbol Grade Name Weight
    BIS A ProShares UltraShort Nasdaq Biotechnology 8.07
    GERM D ETFMG Treatments Testing and Advancements ETF 6.36
    BBH D Market Vectors Biotech ETF 6.3
    FBT D First Trust Amex Biotech Index Fund 5.42
    IBBQ D Invesco Nasdaq Biotechnology ETF 5.31
    View all Treatment Of Hemophilia ETFs...
    Compare ETFs
    Compare BBH to FBT Compare GERM to BBH Compare GERM to FBT

        Treatment Of Hemophilia Stocks Recent News

        Date Stock Title
        Apr 23 CNTA Centessa Pharmaceuticals announces $100M proposed public offering of American Depositary Shares
        Apr 23 CNTA Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
        Apr 23 BIIB Biogen Q1 2024 Earnings Preview
        Apr 23 BIIB Should You Be Confident in Biogen (BIIB)?
        Apr 22 CNTA Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
        Apr 21 BIIB Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
        Apr 19 ALNY How Is The Market Feeling About Alnylam Pharmaceuticals?
        Apr 19 BIIB What's in Store for Biogen (BIIB) This Earnings Season?
        Apr 19 BIIB Gear Up for Biogen (BIIB) Q1 Earnings: Wall Street Estimates for Key Metrics
        Apr 18 BIIB Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
        Apr 18 ALNY Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
        Apr 17 BIIB Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hemophilia Acute Intermittent Porphyria Biopharmaceutical Biotechnology Clinical Development Deficiency Hemophilia A Idiopathic Pulmonary Fibrosis Lupus Spinal Muscular Atrophy Adeno Associated Virus Alipogene Tiparvovec Alnylam Pharmaceuticals Alpha 1 Antitrypsin Alpha 1 Antitrypsin Deficiency Alzheimer's Disease Amyloid Amyloidosis Antitrypsin Deficiency Applied Genetics
        Treatment Of Hemophilia

        Treatment of hemophilia typically involves the use of replacement therapy, which involves infusions of clotting factor concentrates. These concentrates are made from donated human plasma and are designed to replace the missing clotting factor in the blood. Other treatments may include physical therapy, medications to reduce pain and swelling, and surgery to repair damaged joints.

        Browse All Tags